Teva Pharmaceutical Industries Ltd. (TEVA)
39.08
-0.05
(-0.13%)
USD |
NYSE |
Oct 07, 11:54
Teva Pharmaceutical Industries Profit Margin (Quarterly) : -13.88% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.88% |
| March 31, 2026 | 9.24% |
| December 31, 2025 | 10.16% |
| September 30, 2025 | 9.71% |
| June 30, 2025 | 6.70% |
| March 31, 2025 | 5.69% |
| December 31, 2024 | -6.55% |
| September 30, 2024 | -8.98% |
| June 30, 2024 | -21.00% |
| March 31, 2024 | -10.93% |
| December 31, 2023 | 10.40% |
| September 30, 2023 | 1.99% |
| June 30, 2023 | -23.34% |
| March 31, 2023 | -6.92% |
| December 31, 2022 | -33.82% |
| September 30, 2022 | 1.68% |
| June 30, 2022 | -6.87% |
| March 31, 2022 | -26.14% |
| December 31, 2021 | -3.68% |
| September 30, 2021 | 7.78% |
| June 30, 2021 | 5.63% |
| March 31, 2021 | 2.12% |
| December 31, 2020 | 3.66% |
| September 30, 2020 | -109.0% |
| June 30, 2020 | 1.38% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.58% |
| December 31, 2019 | 1.71% |
| September 30, 2019 | -7.51% |
| June 30, 2019 | -16.06% |
| March 31, 2019 | -2.34% |
| December 31, 2018 | -73.40% |
| September 30, 2018 | -4.35% |
| June 30, 2018 | -3.53% |
| March 31, 2018 | 22.39% |
| December 31, 2017 | -217.3% |
| September 30, 2017 | 10.86% |
| June 30, 2017 | -104.4% |
| March 31, 2017 | 11.35% |
| December 31, 2016 | -15.00% |
| September 30, 2016 | 7.37% |
| June 30, 2016 | 4.80% |
| March 31, 2016 | 13.16% |
| December 31, 2015 | 10.20% |
| September 30, 2015 | 2.41% |
| June 30, 2015 | 10.89% |
| March 31, 2015 | 8.93% |
| December 31, 2014 | 13.44% |
| September 30, 2014 | 17.06% |
| June 30, 2014 | 14.77% |
| March 31, 2014 | 14.79% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 30.88% |
| Bristol Myers Squibb Co. | 25.54% |
| Merck & Co., Inc. | -8.06% |
| RedHill Biopharma Ltd. | -- |
| Johnson & Johnson | 21.86% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 9.23% |
| Return on Assets | 1.75% |
| Return on Invested Capital | 2.84% |
| Gross Profit Margin (Quarterly) | 52.07% |
| Operating Margin (Quarterly) | 3.78% |
| Return on Net Operating Assets | 2.16% |